Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis

M Grecescu, M Grecescu

Abstract

Rationale: Visual impairment is one of the most common clinical manifestations of multiple sclerosis (MS). Some multiple sclerosis patients complain of poor vision although the Snellen visual acuity is 20/20. This study reveals that sensitive measurements like visual evoked potential (VEP) and optical coherence tomography (OCT) can evidence subclinical disturbances of visual pathway. These methods examine the relation between the visual function (VEP) and retinal nerve fiber layer (RNFL) thickness, as a structural biomarker for axonal loss in patients with multiple sclerosis (MS). The findings in this study indicate the utility of combining structural and functional testing in clinical research on patients with MS.

Purpose: To detect visual impairment in a population of visually asymptomatic patients affected by clinically definite multiple sclerosis (MS) and to compare the utility of optical coherence tomography (OCT) versus visual evoked potentials (VEP).

Material and methods: Fourteen patients (28 eyes) affected by clinically definite MS, without a history of optic neuritis and asymptomatic for visual disturbances, were initially fully examined (visual acuity, ocular fundus, biomicroscopy) from an ophthalmic point of view and then measured by OCT (RNFL thickness) and VEP. Patients with a history of glaucoma or other retinal or optic nerve disease were excluded.

Results: Of fourteen patients (28 eyes), VEP was abnormal in 11 cases (78,57%) and OCT (RNFL thickness) was abnormal in 5 cases (35,71%), while 3 patients had no abnormalities on neither tests.

Conclusions: Optical coherence tomography (OCT) is less sensitive than visual evoked potentials (VEPs) in detecting visual subclinical impairment in patients with multiple sclerosis (MS). VEP remains the preferred test for the detection of clinical and subclinical optic neuritis. OCT may provide complementary information to VEP in cases with clinical definite MS and represent a valuable research instrument for the study of optic nerve disease in populations. The findings in this study reveal the utility of combining structural and functional testing in clinical research on patients with MS.

Keywords: Optic coherence tomography (OCT); Retinal nerve fiber layer (RNFL); multiple sclerosis (MS); visual evoked potential (VEP).

Figures

Fig. 1
Fig. 1
Optical Coherence Tomography. A patient with MS and no visual symptoms. Note the thinning of RNFL at the right eye (87 µm)
Fig. 2
Fig. 2
Visual evoked potential. A patient with MS with no subjective visual symptoms. Note the delayed latency of P100 wave over 115ms at both eyes

References

    1. Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, Cross AH. Optical coherence tomografhy is less sensitive than visual evoked potentials in optic neuritis. Neurology. 2009 Jul 7;73,1:46–52. doi: 10.1212/WNL.0b013e3181aaea32.
    1. Cheng H, Laron M, Schiffman JS, Tang RA, Frishmann LJ. The Relationship between Visual Field and Retinal Nerve Fiber Measurements in Patients with Multiple Sclerosis. Investigative Ophtalmology &Visual Science. 2007 Dec;48, 12:5798–5805.
    1. Sakai RE, Feller DJ, Galletta KM, Galetta SL, Balcer LJ. Vision in Multiple Sclerosis (MS): The Story, Structure-Function Correlations, and Models for Neuroprotection. J.Neuroophtalmol. 2011 Dec;31(4):362–373. doi:10.1097/WNO.0b013e18238937f.
    1. Cettomai D, Pulicken M, Gordon Lipkin E, Salter A, Frohman TC, Conger A, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Arch Neurol. 2008;65(9):1218–1222.
    1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography
    1. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383–391.
    1. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963–969.
    1. Noval S, Contreras I, Rebolleda G, Munoz-Negrete F. Optical coherence tomography in optic neuritis [letter] Ophtalmology. 2007;114(1):200.
    1. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis, I: abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992;55(9):747–752.
    1. Warner J, Lessell S. Neuro-ophtalmology of multiple sclerosis. Clin Neurosci. 1994;2(3-4):180–188.
    1. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophtalmology. 2006;113(2):324–332.
    1. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31(1):286–293.
    1. Pulicken M, Gordon–Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007;69(22):2085–2092.
    1. Sergott RC. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophtalmol. 2005;16(6):346–350.
    1. Shandiz JH, Nourian A, Hossaini MB, Moghaddam HO, Yekta AA, Sharifzadeh L, Marouzi P. Contrast Sensitivity versus Visual Evoked Potentials in Multiple Sclerosis. Journal of Ophthalmology and Vision Research. 2010;5(3):175–181.
    1. Bundez DI, Anderson Dr, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophtalmology. 2007;114:1046–1052.
    1. Khanifar AA, Parlitsis GJ, Erlich JR, Aaker GD, D` Amico DJ, Gauthier SA, Kiss S. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clinical Ophtalmology. 2010;4:1007–1013.
    1. Costello F, Hodge W, Pan Yi, et al. Retinal nerve fiber layer and future risk of multiple sclerosis. Can J Neurol Sci. 2008;35:482–487.
    1. Parisi V, Manni G, Spadaro M, et al. Correlations between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophtalmolog. Vis Sci. 1999;40:2520–2527.
    1. Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C. Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity. Investigative Ophtalmology & Visual Science. 2005 Apr;46, 4:1264–1268.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner